Moderna Inc (NAS:MRNA)
$ 125.67 0 (0%) Market Cap: 48.16 Bil Enterprise Value: 40.89 Bil PE Ratio: 0 PB Ratio: 3.75 GF Score: 68/100

Moderna Inc at Needham Healthcare Conference Transcript

Apr 15, 2020 / 02:40PM GMT
Release Date Price: $37.25 (+7.47%)
Alan Carr
Needham & Company, LLC, Research Division - Senior Analyst

Good morning, everyone. I'm Alan Carr, analyst at -- research analyst in Biotech at Needham & Company, and welcome to the second day of the 19th Annual Needham Healthcare Conference, and of course, our first virtual health care conference. I've got Lorence Kim, CFO of Moderna, with us here today.

How are you doing, Lorence?

Lorence H. Kim
Moderna, Inc. - CFO & Treasurer

Doing very well, Alan. Thank you for inviting us.

Questions & Answers

Alan Carr
Needham & Company, LLC, Research Division - Senior Analyst

All right. So you had a long day yesterday. I figured we might start off with maybe a few high-level comments that you have about what was important and new yesterday from your vaccine programs. And we can sort of touch on COVID-19 a little bit after you go through the day yesterday.

Lorence H. Kim
Moderna, Inc. - CFO & Treasurer

Sure. Thanks, Alan. So yes,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot